# A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

> **NCT06585774** · PHASE3 · RECRUITING · sponsor: **Incyte Corporation** · enrollment: 240 (estimated)

## Conditions studied

- Chronic Graft-versus-host-disease

## Interventions

- **DRUG:** INCA034176
- **DRUG:** Placebo
- **DRUG:** Corticosteroids

## Key facts

- **NCT ID:** NCT06585774
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-21
- **Primary completion:** 2027-09-28
- **Final completion:** 2030-03-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06585774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06585774, "A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease". Retrieved via MORVS 2026-10-29 from https://api.morvs.ai/clinical/NCT06585774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*